RNAimmune Patents – Insights & Stats (Updated 2024)

RNAimmune has a total of 31 patents globally. Of these 31 patents, more than 87% patents are active. The United States of America is where RNAimmune has filed the maximum number of patents, followed by Singapore and China. Parallelly, The United States of America seems to be the main focused R&D center and also USA is the origin country of RNAimmune.

RNAimmune was founded in the year 2020. RNAimmune, a biotechnology startup specializing in messenger RNA (mRNA) technology, boasts over two decades of experience in manipulating and enhancing this adaptable molecule for therapeutic applications. Central to RNAimmune’s unique approach is leveraging mRNA as a conduit to prompt the body to generate specific proteins, empowering it to combat various diseases effectively.

Do read about some of the most popular patents of RNAimmune which have been covered by us in this article and also you can find RNAimmune patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over RNAimmune patent portfolio.

How many patents does RNAimmune have?

RNAimmune has a total of 31 patents globally. These patents belong to 6 unique patent families. Out of 31 patents, 27 patents are active.

How Many Patents did RNAimmune File Every Year?

RNAimmune Patents Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantRNAimmune Applications FiledRNAimmune Patents Granted
20233
20228
202120

How many RNAimmune patents are Alive/Dead?

Worldwide Patents

RNAimmune Patents Legal Trends

How Many Patents did RNAimmune File in Different Countries?

RNAimmune Patents Worldwide Filing

Countries in which RNAimmune Filed Patents

CountryPatents
United States Of America3
China2
Singapore2
New Zealand2
Europe (EPO)2
Taiwan2
Canada2
Australia2
Israel2
Japan2
Hong Kong (S.A.R.)1
Brazil1
South Africa1
Mexico1

Where are Research Centers of RNAimmune Patents Located?

The Research Centre for all the RNAimmune patents is the United States of America.

Best RNAimmune Patents

US20220040292A1 is the most popular patent in the RNAimmune portfolio. It has received 3 citations so far from companies like BioNTech.

List of RNAimmune Patents

RNAimmune PatentsTitle
US20230355527A1Compounds And Compositions For Drug Delivery
US20230108926A1Composition And Method Of Mrna Vaccines Against Novel Coronavirus Infection
US20220040292A1Composition And Method Of Mrna Vaccines Against Novel Coronavirus Infection
EP4228679A1Pan-Ras Mrna Cancer Vaccines
EP4100066A2Composition And Method Of Mrna Vaccines Against Novel Coronavirus Infection
CN116917470APan-Ras Mrna Cancer Vaccine
CN115297892ACompositions And Methods Of Mrna Vaccines Against Novel Coronavirus Infection
JP2023546133APan-Ras Mrna Cancer Vaccine
WO2023196615A1Compounds And Compositions For Drug Delivery
WO2023091766A3Compositions And Methods Of Ribonucleic Acid Respiratory Syncytial Virus (Rsv) Vaccines
TW202330922ACompositions And Methods Of Ribonucleic Acid Respiratory Syncytial Virus (Rsv) Vaccines
TW202328166AComposition And Methods Of Mrna Vaccines Against Novel Coronavirus Infection
AU2021360796A1Pan-Ras Mrna Cancer Vaccines
IL302065APan-Ras Mrna Cancer Vaccines
SG11202302776TAPan-Ras Mrna Cancer Vaccines
JP2023512833ACompositions And Methods Of Mrna Vaccine Against Novel Coronavirus Infection
WO2023018831A9Composition And Methods Of Mrna Vaccines Against Novel Coronavirus Infection
SG11202300704XAComposition And Method Of Mrna Vaccines Against Novel Coronavirus Infection
CA3222139A1Multiplexed Tp53 And Pan-Ras Mrna Cancer Vaccines
IL295360AComposition And Method Of Mrna Vaccines Against Novel Coronavirus Infection
AU2021216443A1Composition And Method Of Mrna Vaccines Against Novel Coronavirus Infection
NZ799236APan-Ras Mrna Cancer Vaccines
NZ791151AComposition And Method Of Mrna Vaccines Against Novel Coronavirus Infection
CA3167257A1Composition And Method Of Mrna Vaccines Against Novel Coronavirus Infection
HK40078180AComposition And Method Of Mrna Vaccines Against Novel Coronavirus Infection
MX2022009688AComposition And Method Of Mrna Vaccines Against Novel Coronavirus Infection.
BR112022015626A2Composition And Methods Of Mrna Vaccines Against New Coronavirus Infection
WO2022261514A3Multiplexed Tp53 And Pan-Ras Mrna Cancer Vaccines
WO2021159118A8Composition And Method Of Mrna Vaccines Against Novel Coronavirus Infection
WO2022081764A1Pan-Ras Mrna Cancer Vaccines
ZA202209695AComposition And Method Of Mrna Vaccines Against Novel Coronavirus Infection

What are RNAimmune key innovation segments?

What Technologies are Covered by RNAimmune?

The chart below distributes patents filed by RNAimmune in different countries on the basis of the technology protected in patents. It also represents the markets where RNAimmune thinks it’s important to protect particular technology inventions.

R&D Focus: How has RNAimmune search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by RNAimmune?

Related Articles

Arashi Vision Patents – Insights & Stats (Updated 2024)

Arashi Vision has a total of 1257 patents globally, out of which 751 have been granted. Of these 1257 patents, more than 87% patents are active. China is where Arashi Vision has filed the maximum number of patents, followed by United States of America and Europe (EPO). Parallelly, China seems

Read More »

Terecircuits Patents – Insights & Stats (Updated 2024)

Terecircuits has a total of 43 patents globally, out of which 22 have been granted. Of these 43 patents, more than 37% patents are active. United States of America is where Terecircuits has filed the maximum number of patents, followed by Europe (EPO) and Taiwan. Parallelly, United States of America

Read More »

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.